Have a personal or library account? Click to login
Heterozygous Deletion in Exons 4-5 of SHOX Gene in a Patient Diagnosed as Idiopathic Short Stature Cover

Heterozygous Deletion in Exons 4-5 of SHOX Gene in a Patient Diagnosed as Idiopathic Short Stature

Open Access
|Sep 2017

References

  1. 1. Montalbano A, Juergensen L, Roeth R et al. - Retinoic acid catabolizing enzyme CYP26C1 is a genetic modifier in SHOX deficiency. EMBO Mol Med. 2016;8:1455-1469.10.15252/emmm.201606623516713527861128
  2. 2. Marchini A, Ogata T, Rappold GA - A Track Record on SHOX: From Basic Research to Complex Models and Therapy. Endocr Rev. 2016;37:417-448.10.1210/er.2016-1036497131027355317
  3. 3. Bertalan R, Halász Z - A SHOX gén vizsgálatának klinikai jelentősége alacsonynövésben. Magy Belorv Arch. 2011;64:284-288.
  4. 4. Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L et al. - A 170P mutation in SHOX gene in a patient not presenting with Madelung deformity. J Clin Pathol. 2012;65:844-846.10.1136/jclinpath-2011-20062622461651
  5. 5. Valetto A, Bertini V, Michelucci A et al. - Short Stature in Isodicentric Y Chromosome and Three Copies of SHOX Gene: Clinical report and Review of Literature. Mol Syndromol. 2016;7:19-25.10.1159/000444430486239327194969
  6. 6. Choi WB, Seo SH, Yoo WH, Kim SY, Kwak MJ - A Leri-Weill dyschondrosteosis patient confirmed by mutation analysis of SHOX gene. Ann Pediatr Endocrinol Metab. 2015;20:162-165.10.6065/apem.2015.20.3.162462334526512353
  7. 7. Donze SH, Meijer CR, Kant SG et al. - The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects. Eur J Endocrinol. 2015;173:611-621.10.1530/EJE-15-045126264720
  8. 8. Albuisson J, Schmitt S, Baron S, Bezieau S, Benito-Sanz S, Heath KE - Clinical utility gene card for: Leri-Weill dyschondrosteosis (LWD) and Langer mesomelic dysplasia (LMD). Eur J Hum Genet 2012; 20(8). doi:10.1038/ejhg.2012.6410.1038/ejhg.2012.64340073922510850
  9. 9. Binder G - Short stature due to SHOX deficiency: genotype, phenotype, and therapy. Horm Res Paediatr. 2011;75:81-89.10.1159/00032410521325865
  10. 10. Rappold G, Blum WF, Shavrikova EP et al. - Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306-313.10.1136/jmg.2006.046581259798017182655
  11. 11. Blum WF, Crowe BJ, Quigley CA et al. - SHOX Study Group: Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:219-228.10.1210/jc.2006-140917047016
  12. 12. Ross JL, Kowal K, Quigley CA et al.- The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. J Pediatr. 2005;147:499-507.10.1016/j.jpeds.2005.04.06916227037
  13. 13. Binder G, Rappold GA - SHOX deficiency disorders. In: Pagon RA, Adam MP, Ardinger HH et al, editors. GeneReviews [Internet]. Seattle, WA: University of Washington 2005. Available at https://www.ncbi.nlm.nih.gov/pubmed/20301394.
  14. 14. Miclea DL, Al Khzouz C, Bucerzan S et al. - Assessment of the SHOX gene and chromosomal abnormalities by molecular and classical cytogenetics in patients with short stature. Acta Endo. 2015;11:463-469.10.4183/aeb.2015.463
  15. 15. Funari MF, Jorge AA, Souza SC et al. - Usefulness of MLPA in the detection of SHOX deletions. Eur J Med Genet. 2010;53:234-238.10.1016/j.ejmg.2010.06.00120538086
DOI: https://doi.org/10.1515/amma-2017-0028 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 155 - 158
Submitted on: May 29, 2017
|
Accepted on: Jul 24, 2017
|
Published on: Sep 23, 2017
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Anna David, Imre Zoltán Kun, Gábor Nyírő, Zsuzsánna Szántó, Attila Patócs, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.